| Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial M Rodríguez-Morán, F Guerrero-Romero Diabetes care 26 (4), 1147-1152, 2003 | 441 | 2003 |
| Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial F Guerrero-Romero, HE Tamez-Perez, G González-González, ... Diabetes & metabolism 30 (3), 253-258, 2004 | 277 | 2004 |
| Low serum magnesium levels and metabolic syndrome F Guerrero-Romero, M Rodriguez-Moran Acta diabetologica 39 (4), 209-213, 2002 | 258 | 2002 |
| Metabolic syndrome among children and adolescents aged 10–18 years M Rodríguez-Morán, B Salazar-Vázquez, R Violante, F Guerrero-Romero Diabetes care 27 (10), 2516-2517, 2004 | 241 | 2004 |
| The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp F Guerrero-Romero, LE Simental-Mendía, M Gonzalez-Ortiz, ... The Journal of Clinical Endocrinology & Metabolism 95 (7), 3347-3351, 2010 | 237 | 2010 |
| The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects LE Simental-Mendía, M Rodríguez-Morán, F Guerrero-Romero Metabolic syndrome and related disorders 6 (4), 299-304, 2008 | 235 | 2008 |
| Lipid-and glucose-lowering efficacy of Plantago Psyllium in type II diabetes M Rodrı́guez-Morán, F Guerrero-Romero, G Lazcano-Burciaga Journal of Diabetes and its Complications 12 (5), 273-278, 1998 | 195 | 1998 |
| Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome F Guerrero‐Romero, M Rodríguez‐Morán Diabetes/metabolism research and reviews 22 (6), 471-476, 2006 | 166 | 2006 |
| Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants F Guerrero-Romero, M Rodríguez-Morán Archives of medical research 36 (3), 250-257, 2005 | 159 | 2005 |
| Increased levels of C-reactive protein in noncontrolled type II diabetic subjects M Rodrı́guez-Morán, F Guerrero-Romero Journal of diabetes and its complications 13 (4), 211-215, 1999 | 159 | 1999 |
| Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial L Barragán-Rodríguez, M Rodríguez-Morán, F Guerrero-Romero Magnesium research 21 (4), 218-223, 2008 | 140 | 2008 |
| Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects F Guerrero-Romero, M Rodriguez-Moran International journal of obesity 26 (4), 469, 2002 | 106 | 2002 |
| The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo … F Guerrero-Romero, M Rodriguez-Moran Journal of human hypertension 23 (4), 245, 2009 | 95 | 2009 |
| Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in children: a case-control study E Mazariegos-Ramos, F Guerrero-Romero, M Rodríguez-Morán, ... The journal of pediatrics 126 (6), 940-942, 1995 | 95 | 1995 |
| Hypomagnesaemia and risk for metabolic glucose disorders: a 10‐year follow‐up study F Guerrero‐Romero, RA Rascón‐Pacheco, M Rodríguez‐Morán, ... European journal of clinical investigation 38 (6), 389-396, 2008 | 93 | 2008 |
| Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients. F Guerrero-Romero, M Rodriguez-Moran, JR Paniagua-Sierra, ... Clinical nephrology 43 (2), 116-121, 1995 | 90 | 1995 |
| Magnesium improves the beta‐cell function to compensate variation of insulin sensitivity: double‐blind, randomized clinical trial F Guerrero‐Romero, M Rodríguez‐Morán European journal of clinical investigation 41 (4), 405-410, 2011 | 85 | 2011 |
| Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment … F Guerrero-Romero, M Rodriguez-Moran Diabetes Care 28 (10), 2588-2590, 2005 | 82 | 2005 |
| Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values F Guerrero-Romero, M Rodrı́guez-Morán Journal of Diabetes and its Complications 14 (5), 272-276, 2000 | 81 | 2000 |
| Proteinuria Is an Independent Risk Factor for Ischemic Stroke in Non–Insulin-Dependent Diabetes Mellitus F Guerrero-Romero, M Rodríguez-Morán Stroke 30 (9), 1787-1791, 1999 | 76 | 1999 |
